As you read this, EVP Media Eugene Lee is gearing up for SxSW Interactive: strapping on his solar-powered backpack, syncing his Pebble, and pumping up his shoes. This will be the best year yet, and you can catch the action by following our Instagram, Twitter or Facebook feeds #CMIEvo.
23andMe is partnering with pharma companies to utilize their data for drug discovery, and has hired a new Chief Science Officer from within the industry to lead the charge. Wall Street Journal reports “The hope is that mutations and other genetic information harbored in the database—along with links to health information customers have provided to 23andMe—will reveal mechanisms and potential drug targets for a range of rare and common diseases.”
Senior Marketing Data Analyst Christine L. Hardy shared this article, explaining: According to recent research, 1 in 5 people have a genetic mutation that allows them to overcome anxiety and stress faster than the rest of us. This mutation functions similarly to marijuana. The article goes on to explain that this gene also can affect whether you become more dependent on marijuana.
And in other gene news, a new study has identified a gene associated with post-traumatic stress disorder.
Adios, competing fitness trackers, say Apple stores.
– Carly Kuper, VP, Strategic Marketing & Corporate Communications
Click here to get The Scoop sent to your inbox daily!